TrialNature communications2019

Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways.

Sergey Yegorov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.